Anti-fibrotic Treatment for Pulmonary Fibrosis Induced by COVID-19: A Case Presentation.
Turk J Anaesthesiol Reanim
; 50(3): 228-231, 2022 Jun.
Article
em En
| MEDLINE
| ID: mdl-35801331
ABSTRACT
Coronavirus disease 19 infection clinical presentation varies from asymptomatic cases to acute respiratory distress syndromes. In some cases, pulmonary fibrosis is observed after or during the disease. Pirfenidone is an agent approved for the treatment of idiopathic pulmonary fibrosis. Here we report a patient treated with pirfenidone for pulmonary fibrosis related to coronavirus disease 19.
Texto completo:
1
Base de dados:
MEDLINE
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article